Publication: 3407

Randomized Phase II Study of PET Response–Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 39 (25) 2803-2815
Year:
2021
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
11
Parents:
2601   2675   2901  
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, UG1CA233180, UG1CA233253, UG1CA233290, UG1CA233331, UG1CA233337, UG1CA233373, UG1CA232760  
Corr. Author:
 
Authors:
                                     
Networks:
CA824, LAPS-CT018, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-NY016, LAPS-OH007, METROMIN, NY021   
Study
CALGB-80803
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
ORIGINAL REPORTS, Gastrointestinal Cancer